This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 7, 2013

Home  About Us  Advocacy   CSHP 2015   Events   Membership   Products & Publications   Programs Resources   Contact Us



 


Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news of interest to hospital pharmacists, selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries; any comments regarding content of this publication should be emailed to CSHP. It should not be understood or implied from the presence of advertisements that CSHP endorses any products or services advertised. MultiView and CSHP are not liable for any delays or inaccuracies in the information contained in this brief, nor for any actions taken or outcomes resulting from relying on the information provided herein.



In this issue:

Regina hospitals face pharmacists shortage
Cause of B.C. norovirus outbreak still unknown
Regulations finalized to establish a prescription drug list
Health Canada: Nasal spray for osteoporosis increases cancer risk
C. diff rates falling but still a concern
Experts: Canada's elderly at high risk of suicide, can't afford mental health care
Levomilnacipran extended-release approved for major depressive disorder
Despite risks, sedatives called 'benzos' widely used across Canada


Regina hospitals face pharmacists shortage
The Leader-Post
The Health Sciences Association of Saskatchewan says there is a severe shortage of hospital pharmacists in a number of Regina hospital wards — including the cardiac care unit and children's ward at the Regina General Hospital. According to the union, the shortage exists because the Regina Qu'Appelle Health Region refuses to replace hospital pharmacists on maternity leave, educational leave or temporary work assignments elsewhere in the region.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Cause of B.C. norovirus outbreak still unknown
CTV News
A sudden, fast-spreading norovirus outbreak that sickened almost half the residents at a Victoria, B.C., seniors' home and may have led to the deaths of nine of them appears to be waning. And now, authorities are trying to figure out how it spread so quickly and sickened so many.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Regulations finalized to establish a prescription drug list
Mondaq
Final regulations that simplify the process to add or remove drugs with prescription status were published on June 19, 2013, although their date of implementation will be December 19, 2013 — six months from the coming into force of the particular statutory provision, included as part of the Jobs, Growth and Long-term Prosperity Act, that authorized the regulations. The regulations will allow pharmacy technicians to transfer prescriptions, in order to reflect provincial legislation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE

Sponsored Content
    •Deep vein thrombosis (DVT) is a condition that affects approximately one in 1,000 persons/year
    •Can result from conditions causing impaired venous return, endothelial injury or dysfunction, or hypercoagulability
    •Often occurs in the upper and lower extremities or the pelvis
    •May be asymptomatic or cause pain and swelling in an extremity
    •Objective testing is crucial because the consequences of misdiagnosis can include fatal pulmonary embolisms


Health Canada: Nasal spray for osteoporosis increases cancer risk
City News
Health Canada says a nasal spray for treating osteoporosis that contains the drug calcitonin will be taken off the market on Oct. 1 due to an increased risk of cancer. A safety review by the federal department found a slightly elevated risk of cancer linked with prolonged use of calcitonin products. Calcitonin is used as a nasal spray to treat osteoporosis in postmenopausal women and as an injection to treat the bone disorder Paget’s disease and high blood calcium.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


C. diff rates falling but still a concern
CMAJ
Ten years after an outbreak of Clostridium difficile killed as many as 2000 people in Quebec, the diarrhea-causing bacterium is infecting fewer people in Canadian hospitals, though it remains a major public health concern. Mandatory reporting and stricter guidelines on antibiotic use and hygiene have helped reduce infection rates, and while reports of infections are still seen in the media, large-scale outbreaks are rare.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Complete Unit Dose Packaging

If your hospital is using automated dispensing cabinets or Bar Code Medication Administration at the bedside you should consider Pentapack unit dose packaging for your orals, liquids, suppositories and ampoules. Pentapack is a complete and inexpensive system which offers a variety of packaging and labelling formats. For more information contact Manrex at 1.800.665.7652 or visit www.manrex.com.
 


Experts: Canada's elderly at high risk of suicide, can't afford mental health care
Ottawa CItizen
Studies show that Canada's elderly are at a much higher risk of suicide than adolescents, and there is growing concern among mental health experts that psychological care may be out of reach for most seniors. Dr. Marnin Heisel, a clinical psychologist and professor at the University of Western Ontario, says lack of public awareness of the issue is a key problem that affects not only the elderly, but their families and the public in general.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Levomilnacipran extended-release approved for major depressive disorder
Pharmacy Practice News
The FDA recently approved levomilnacipran extended-release (ER) capsules for treatment of major depressive disorder in adults. A selective serotonin and norepinephrine reuptake inhibitor, levomilnacipran ER is to be taken in a dose range of 40 to 120 mg once daily with or without food. It was discovered by France's Pierre Fabre Laboratories and codeveloped by Forest Laboratories.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Despite risks, sedatives called 'benzos' widely used across Canada
Windsor Star
When Shirley was handed a three-month prescription for Ativan, her doctor insisted the popular sedative was just an "innocent little thing" to help her sleep. But after her doctor yanked her off the drug cold turkey, rather than slowly tapering off the dosage, Shirley plunged into a deep withdrawal. Over the next year and a half she was cycled through more than a dozen benzodiazepines and antidepressants, locked up in a psych ward and diagnosed with a slew of mental disorders.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Making Us A Wise Choice

As a manufacturer of generic drugs our flexibility and turnaround times exceed the industry standards.
 


FEATURED ARTICLE
MOST POPULAR ARTICLE
TRENDING ARTICLE
McKesson realigns Ontario network
MM&D
Pharmaceutical and medical supplies distributor McKesson Canada is making a major change to its Ontario operations — one that will result in both job gains and job losses. The Montreal, QC-based company, which has operated in Canada for over 100 years, is closing its distribution centre located in Mississauga, ON. The facility is scheduled to shut down in spring 2014.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Pharmacist: Nothing funny about so-called 'Visine prank'
Waterloo Region Record
Over-the-counter eye drops are safe products when they're used as intended, but can have dangerous consequences when abused as a prank or something more malicious, says the director of the pharmacy school at the University of Waterloo.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Shoppers Drug Mart's pharmacist associate model a hidden jewel for Loblaw
Financial Post
If Loblaw Companies successfully buys Shoppers Drug Mart, it will not only inherit the pharmacy retailer's vast network of stores — particularly key locations in the hearts of Canada's urban centres — it will also benefit from the advantages afforded by the owner-operators of those stores: pharmacists.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Can't remember to take your meds? There's an app for that (Huffington Post Canada)
Proposed regulations on labelling of prescription and non-prescription pharmaceuticals (Mondaq)
Hospitals announce major staff realignment (The Windsor Star)

Don't be left behind. Click here to see what else you missed.


 


CSHP e-Newsbrief

Frank Humada, Director of Publishing, MultiView 289.695.5422
Download media kit

Siobhan Cole, Senior Content Editor, MultiView 289.695.5423   
Contribute news


To unsubscribe, click here.

Recent issues

Aug. 7, 2013
July 31, 2013
July 24, 2013
July 17, 2013






50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8